2Yang Q,Graham TE, Mody N. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes [ J ]. Nature, 2005,436:356-362.
3Ueland T, Dalsoren T, Voldner N. Retinol-binding protein- 4 is not strongly associated with insulin sensitivity in norreal pregnancies [ J ]. Eur J Endocrinol, 2008,159 : 49-54.
4Krugluger W, Krzyzanowska K, Zemany L, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes [ J ]. Diabetologia, 2008, 51:1115-1122.
5Craig RL, Chu WS, Elbein SC. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits [ J ]. Mol Genet Metab, 2007,90 : 338- 344.
二级参考文献10
1陈敏章.中华内科学（第1版）[M].北京:人民卫生出版社,1999.1968.
2叶任高.内科学（第5版）[M].北京:人民卫生出版社,2000.159.
3Wall PD, Deucy EE, Glantz JC. Links Vertical skin incisions and wound complications in the obese parturient. Obstet Gynecol, 2003, 102:952-956
4Lu GC, Rouse DJ, DuBard Met ol. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol, 2001, 185:845-849
5Cedergren MI . Links Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol, 2004, 103 (2): 219-224
6Kaiser PS, Kirby RS. Obesity as a risk factor for cesarean in a low - risk population. Obstet Gynecol, 2001, 97:39 -43
2Lee DC, Lee JW, lm JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents.Metabolism, 2007,56 ( 3 ) :327-331.
3Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 2005,436(7049) :356-362.
4von Eynatten M, Lepper PM, Liu D, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia, 2007,50(9) :1930-1937.
5Gavi S, Stuart LM, Kelly P, et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab, 2007,92(5 ) : 1886-1890.
6Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med ,2006,354(24) :2552-2563.
7Freeman DJ, Norrie J, Sattar N , et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the west of Scotland Coronary Prevention Study . Circulation, 2001, 103 (3) : 357-362.
8Yao-Borengasser A, Vanna V, Bodies AM, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab, 2007,92 (7) :2590-2597.
9Christopher J. Nolan, Murthy S.R. Madiraju, et al. Fatty Acid Signaling in the B-Cell and Insulin Secretion . Diabetes, 2006, 55(S2) :S16-S23.
10Lain TK, van de Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab,2003, 284(2) : E281-290.
